Evidence map›Paper›PMID 26435066›Full record

ReviewCellular & molecular immunology2016

Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine.

Huabin Liang, Min Lee, Xia Jin

Open access · bronzeAbstract readReview
In one paragraph

Review in Cellular & molecular immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Animal models for dengue vaccine development and testing.Clinical and experimental vaccine research · 2017
    Review
  12. Review
  13. Article
  14. Meeting report: the 4Zoological research · 2016
    Article
  15. Vaccinations for Neuroinfectious Disease: A Global Health Priority.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2016
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Huabin LiangViral Disease and Vaccine Translational Research Unit, and Vaccine Centre, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China.
Min LeeViral Disease and Vaccine Translational Research Unit, and Vaccine Centre, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China.
Xia JinViral Disease and Vaccine Translational Research Unit, and Vaccine Centre, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China.
Institut Pasteur of Shanghai · CNChinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flaviviruses comprise approximately 70 closely related RNA viruses. These include several mosquito-borne pathogens, such as yellow fever virus (YFV), dengue virus (DENV), and Japanese encephalitis virus (JEV), which can cause significant human diseases and thus are of great medical importance. Vaccines against both YFV and JEV have been used successfully in humans for decades; however, the development of a DENV vaccine has encountered considerable obstacles. Here, we review the protective immune responses elicited by the vaccine against YFV to provide some insights into the development of a protective DENV vaccine.

Indexed as

Antibodies, ViralCytokinesDEAD-box RNA HelicasesDendritic CellsDengueDengue VaccinesDengue VirusHost-Pathogen InteractionsHumansImmunity, InnateLymphocytesNucleoside-TriphosphatasePhylogenyRNA HelicasesSerine EndopeptidasesViral Nonstructural ProteinsAntibodies, ViralCytokinesDEAD-box RNA HelicasesDengue VaccinesNS2B protein, flavivirusNS3 protein, flavivirusNucleoside-TriphosphataseRNA HelicasesSerine EndopeptidasesViral Nonstructural ProteinsViral ProteasesYellow Fever Vaccine

Identifiers

PMID26435066
PMCPMC4711684
OpenAlexW2219043314

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.